Date Insider Type Main position Quantity % Market Cap. Importance
21/04/21 Other 0 0% -
21/04/21 Other

Chief Executive Officer

0 0%
21/04/21 Other 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-90.00% - - 59
-0.71%-6.35%-2.99%+9.59% 4.55TCr
+0.21%-2.98%+337.74%+519.55% 4.37TCr
+1.74%-2.24%+39.82%+20.76% 4.31TCr
+1.38%-3.28%+6.84%+67.62% 3.94TCr
-1.44%-5.26%+8.97%+39.76% 3.19TCr
+0.87%-2.60% - - 1.73TCr
+0.75%-0.64%+19.75%+110.17% 1.64TCr
-0.31%-2.78%+10.78%+31.02% 1.42TCr
+1.93%-3.55%+82.00%+41.17% 1.33TCr
Average +0.44%-3.57%+62.86%+104.96% 2.94TCr
Weighted average by Cap. +0.41%-3.67%+74.57%+124.26%
Logo Avisa Diagnostics Inc.
Avisa Diagnostics Inc is a United States-based clinical-stage medical device company. The Company is engaged in developing drug/device biomarker technology platform that enables the ultra rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates.
Employees
-
  1. Stock Market
  2. Stocks
  3. FOGCF Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!